INTRODUCTION
Urticaria is one of the most commonly conditions observed in dermatology daily practice, affecting 15% to 30% of the population. 1 Wheal is its elementary dermatological lesion, characterized by being itchy and have central edema with varied size, surrounded by a reflex erythema and with ephemeral nature; furthermore, the skin returns to its normal aspect usually in a period that varies from one to 24 hours. 2 Urticaria is classified, from the point of view of duration of its evolution, in acute (less than six weeks) or chronic (over six weeks). 3 The physiopathology of chronic urticaria (CU) has long been associated with anxiety and allergy to foods or its additives, but today it is considered the participation of autoimmune mechanisms and coagulation factors. 4 It is known that degranulation of mast cells or skin basophils is its initial stimulation. By releasing potent vasoactive mediators, vasodilation is induced, increasing capillary permeability and resulting in erythema and papule formation.
5
The main vasoactive mediator involved in CU is histamine, however there are other mediators such as arachidonic acid metabolites, leukotrienes (LTC4, D4 and E4), prostaglandin D2, serotonin, acetylcholine, platelet-activating factor, heparin, codeine, anaphylatoxins C3 and C5a, cytokines and neurotransmitters released from cutaneous nerve endings. 6 These mediators participate in attracting other inflammatory cells such as neutrophils, lymphocytes, and particularly eosinophils, which play a role in inflammation maintenance for release of other substances, characterizing the cellular infiltrate of the disease. by participating in mast cell activation, inflammation and the formation of vascular leakage. 8 In addition, patients with CU often show signs of thrombin generation, as a result of the extrinsic pathway activation of coagulation and fibrinolysis, and have mean levels of D-dimer slightly higher, being a participant substance of this pathway. 4 The clinical importance of characterizing the inflammatory infiltrate resides in the presence of a subgroup of patients presenting eosinophil or neutrophil urticaria, which may be resistant to treatment with antihistamines, but which responds to a combination of antihistamine with other drugs. 6 In addition to the improvement and optimization of the treatment of disease, to establish a relation between inflammatory infiltrate and clinical score of severity of the disease can also aid in the prognosis of the disease and therefore in its management. The aim of this study is to evaluate the inflammatory infiltrate present in CU biopsies and correlate it with the clinical activity of the disease and its response to treatment. To meet the inclusion criteria, patients had to: 1) come from the urticaria clinic; 2) present or have presented the disease for a period longer than six weeks; 3) be older than 18 years; 4) understand and sign the informed consent form; and 5) have undergone biopsy at some time of the disease.
METHODS

This is
Exclusion criteria were: 1) duration of urticaria shorter than six weeks; 2) failure to sign the informed consent form; 3) absence of biopsy of the lesions; and 4) age younger than 18 years. Patients with CU were classified according to UAS, which is determined by the number of daily urticaria and the intensity of pruritus, 1 as shown in table 1. Clinical score is considered mild when UAS is from 0 to 2 points; moderate, when it is from 3 or 4 points; and high, when it is from 5 to 6 points.
The biopsy material was fixed in formalin 10% and stained with hematoxylin and eosin (HE) and subjected to microscopy at magnification of 400 times. 
DISCUSSION
Our study showed a higher percentage of female patients, which is in accordance with the demographic profile of the disease that is already known, but the proportion found was 5.84 women for one man, while in literature the proportion is 2:1. 9 The type and Thus, the association found in this study between the clinical score of greater severity and eosinophil infiltrate shows that, when the eosinophil predominates, there is more than an activation pathway of the disease -the direct and also the indirect -reinforcing its development and aggravating its clinical picture.
In our study, the relation between the type of infiltrate and response to treatment wasn't identified. Urticaria presents a wide range of etiologies, and its onset comes from different cellular activation orders. Thus, the therapeutic response is very variable and susceptible to idiosyncrasies, because each patient has a trigger mechanism of the disease.
In our study, no statistical significance between the values of IgE and the types of inflammatory infiltrate was found, but the me- 
